JP7235512B2 - キャッピング工程を有さないチオール化オリゴヌクレオチドの合成 - Google Patents

キャッピング工程を有さないチオール化オリゴヌクレオチドの合成 Download PDF

Info

Publication number
JP7235512B2
JP7235512B2 JP2018567264A JP2018567264A JP7235512B2 JP 7235512 B2 JP7235512 B2 JP 7235512B2 JP 2018567264 A JP2018567264 A JP 2018567264A JP 2018567264 A JP2018567264 A JP 2018567264A JP 7235512 B2 JP7235512 B2 JP 7235512B2
Authority
JP
Japan
Prior art keywords
formula
compound
oligonucleotide
agent
steps
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018567264A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019518778A (ja
JP2019518778A5 (enExample
Inventor
シー，シアーンリン
ヤン，ジミン
キースマン，ウィリアム・エフ
フィロン，ヤニック
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biogen MA Inc
Original Assignee
Biogen MA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen MA Inc filed Critical Biogen MA Inc
Publication of JP2019518778A publication Critical patent/JP2019518778A/ja
Publication of JP2019518778A5 publication Critical patent/JP2019518778A5/ja
Application granted granted Critical
Publication of JP7235512B2 publication Critical patent/JP7235512B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/34—Spatial arrangement of the modifications
    • C12N2310/341—Gapmers, i.e. of the type ===---===
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2018567264A 2016-06-24 2017-06-22 キャッピング工程を有さないチオール化オリゴヌクレオチドの合成 Active JP7235512B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662354433P 2016-06-24 2016-06-24
US62/354,433 2016-06-24
PCT/US2017/038643 WO2017223258A1 (en) 2016-06-24 2017-06-22 Synthesis of thiolated oligonucleotides without a capping step

Publications (3)

Publication Number Publication Date
JP2019518778A JP2019518778A (ja) 2019-07-04
JP2019518778A5 JP2019518778A5 (enExample) 2020-07-30
JP7235512B2 true JP7235512B2 (ja) 2023-03-08

Family

ID=59276874

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018567264A Active JP7235512B2 (ja) 2016-06-24 2017-06-22 キャッピング工程を有さないチオール化オリゴヌクレオチドの合成

Country Status (7)

Country Link
US (1) US11142545B2 (enExample)
EP (1) EP3475292B1 (enExample)
JP (1) JP7235512B2 (enExample)
KR (2) KR102722183B1 (enExample)
CN (1) CN109689668B (enExample)
ES (1) ES2999138T3 (enExample)
WO (1) WO2017223258A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016040748A1 (en) 2014-09-12 2016-03-17 Ionis Pharmaceuticals, Inc. Compositions and methods for detection of smn protein in a subject and treatment of a subject
ES2901099T3 (es) 2017-07-10 2022-03-21 Geron Corp Proceso mejorado para la preparación de imetelstat
EP3966328A4 (en) 2019-05-06 2023-10-18 University Of Massachusetts Anti-c9orf72 oligonucleotides and related methods
CN110468171B (zh) * 2019-09-20 2021-10-29 凯莱英医药集团（天津）股份有限公司 核酸的合成方法
IL293824A (en) 2019-12-13 2022-08-01 Alnylam Pharmaceuticals Inc Compositions of RNA material (c9orf72) human chromosome 9 open reading frame 72 and methods of using them
AU2021225957A1 (en) 2020-02-28 2022-09-08 Ionis Pharmaceuticals, Inc. Compounds and methods for modulating SMN2
CN114685572B (zh) * 2022-06-02 2022-08-30 上海百力格生物技术有限公司 用于mgb核酸探针合成的氧化剂组合物及探针的合成方法
WO2024061842A1 (en) 2022-09-19 2024-03-28 Bachem Holding Ag Improved oligonucleotide synthesis
EP4755898A1 (en) 2023-08-02 2026-06-10 Nitto Denko Corporation Method for producing oligonucleotide
KR20260056189A (ko) * 2023-08-14 2026-04-24 애로우헤드 파마슈티컬스 인코포레이티드 올리고뉴클레오티드 합성 방법
WO2025165064A1 (ko) * 2024-02-02 2025-08-07 에스티팜 주식회사 올리고뉴클레오티드 합성을 위한 개선된 방법
WO2025234897A1 (ru) * 2024-05-07 2025-11-13 Акционерное общество "ГЕНЕРИУМ" Способ получения тиофосфатных олигонуклеотидов для терапевтического применения
WO2025235761A1 (en) 2024-05-09 2025-11-13 Biogen Ma Inc. Reagents and processes for preparing oligonucleotides
WO2026082783A1 (en) 2024-10-17 2026-04-23 F. Hoffmann-La Roche Ag Synthesis of thiolated oligonucleotides without capping and without recirculation of the thiolating agent
WO2026110089A1 (en) 2024-11-22 2026-05-28 Glaxosmithkline Intellectual Property Development Limited Methods of preparing and purifying oligonucleotides

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087491A (en) * 1993-01-08 2000-07-11 Hybridon, Inc. Extremely high purity oligonucleotides and methods of synthesizing them using dimer blocks
US5614621A (en) * 1993-07-29 1997-03-25 Isis Pharmaceuticals, Inc. Process for preparing oligonucleotides using silyl-containing diamino phosphorous reagents
US6809195B1 (en) * 2000-08-16 2004-10-26 Isis Pharmaceuticals, Inc. Process for the preparation of oligonucleotides
EP1386925A1 (en) * 2002-07-31 2004-02-04 Girindus AG Method for preparing oligonucleotides
PT2548560E (pt) 2005-06-23 2015-09-22 Isis Pharmaceuticals Inc Composições e métodos de modulação da excisão-união de smn2
KR20220084437A (ko) 2009-06-17 2022-06-21 바이오젠 엠에이 인코포레이티드 대상에게서 ｓｍｎ２ 스플라이싱을 조정하기 위한 조성물 및 방법
US8642755B2 (en) * 2009-06-30 2014-02-04 Agilent Technologies, Inc. Use of thioacetic acid derivatives in the sulfurization of oligonucleotides with phenylacetyl disulfide
CA2858576A1 (en) * 2011-12-06 2013-06-13 Research Institute At Nationwide Children's Hospital Non-ionic, low osmolar contrast agents for delivery of antisense oligonucleotides and treatment of disease
US9758546B2 (en) * 2013-10-21 2017-09-12 Ionis Pharmaceuticals, Inc. Method for solution phase detritylation of oligomeric compounds
HUE050704T2 (hu) 2014-04-01 2020-12-28 Biogen Ma Inc Összetételek a SOD-1 expressziójának modulálására
TWI706958B (zh) * 2015-03-10 2020-10-11 美商艾杜諾生物科技公司 活化「干擾素基因刺激因子」依賴性訊息傳導之組合物及方法
JOP20190218A1 (ar) * 2017-03-22 2019-09-22 Boehringer Ingelheim Int مركبات ثنائية النيوكليوتيدات حلقية معدلة

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ZACHARIA S CHERUVALLATH，ORGANIC PROCESS RESEARCH AND DEVELOPMENT，米国，2000年05月，VOL:4, NR:3，PAGE(S):199 - 204

Also Published As

Publication number Publication date
KR20190020743A (ko) 2019-03-04
EP3475292B1 (en) 2024-09-18
CN109689668B (zh) 2023-02-17
KR20230133947A (ko) 2023-09-19
JP2019518778A (ja) 2019-07-04
US20190161513A1 (en) 2019-05-30
KR102722183B1 (ko) 2024-10-24
ES2999138T3 (en) 2025-02-24
CN109689668A (zh) 2019-04-26
WO2017223258A1 (en) 2017-12-28
EP3475292A1 (en) 2019-05-01
US11142545B2 (en) 2021-10-12

Similar Documents

Publication Publication Date Title
KR102722183B1 (ko) 캡핑 단계 없이 티올화된 올리고뉴클레오타이드의 합성
JP7824080B2 (ja) オリゴヌクレオチドの収束液相合成
DE69106376T2 (de) Verfahren zum verbinden von nukleosiden mit einer siloxanbrücke.
EP2277886B1 (en) The use of n-alkyl imidazole for sulfurization of oligonucleotides with an acetyl disulfide
US6166198A (en) Methods for oligonucleotide synthesis
CN112004928A (zh) 寡核苷酸组合物及其使用方法
US20100331533A1 (en) Use Of Thioacetic Acid Derivatives In The Sulfurization Of Oligonucleotides With Phenylacetyl Disulfide
JP7085739B2 (ja) 人工ヌクレオシド及び人工ヌクレオチド並びに人工オリゴヌクレオチド
CN120129688A (zh) 用于制备高度纯化的5′-加帽寡核苷酸的高效方法
CA3255238A1 (en) LIPID MONOMERS FOR THERAPEUTIC ADMINISTRATION OF RNA
TWI848125B (zh) 使用經修改之氧化準則製備寡核苷酸之方法
WO2019131719A1 (ja) 高脂溶性ホスホラミダイトの製造
TW200528464A (en) Process for fluorocytidine derivatives
JP7777452B2 (ja) 核酸オリゴマーの製造方法
AU2022291626A1 (en) Improved process for preparing imetelstat
CN100484949C (zh) 用于rna寡核苷酸合成中的核苷亚磷酰胺及其合成方法
HK40008182A (en) Synthesis of thiolated oligonucleotides without a capping step
HK40008182B (en) Synthesis of thiolated oligonucleotides without a capping step
EP3154996B1 (en) Protecting groups for "z nucleotide" and methods thereof
WO2024019137A1 (ja) オリゴヌクレオチドの製造方法
JP7423533B2 (ja) 配糖体化合物の製造方法
CN118076620A (zh) 2’修饰嘧啶核苷的制造方法
WO2025244124A1 (ja) 核酸オリゴマーの製造方法
US20100010069A1 (en) Extended Length Borane Phosphonate Nucleic Acid Compounds
Eritja Casadellà et al. Synthesis and Properties of Oligodeoxynucleotides Carrying 2-Aminopurine

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200618

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200618

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210728

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211027

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220318

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220617

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220927

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221220

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230201

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230224

R150 Certificate of patent or registration of utility model

Ref document number: 7235512

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150